USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cymmetrik Enterprise Co., Ltd.

USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

11.8

Avg claims per patent

5-year filing velocity

The verdict

Cymmetrik holds 5 US patents across 10 technology areas, rank #45,706 of 50,000 tracked assignees.

#45,706
of 50,000 US assignees by volume: Top 63%
by Innovation Score (31.1/100): 11.8
avg claims per patent

Portfolio overview

Cymmetrik Enterprise Co., Ltd. has been granted 5 US utility patents between 2020 and 2025, placing Cymmetrik Enterprise Co., Ltd. at rank #45,706 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.8 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Cymmetrik Enterprise Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Cymmetrik sits between Cyber Physical Systems Llc (5 patents, rank #45,702) and Cytoaurora Biotechnologies, Inc. (5 patents, rank #45,710) - the closest US assignees by grant volume. The composite Innovation Score of 31.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cymmetrik Enterprise Co., Ltd.'s 11.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cymmetrik Enterprise Co., Ltd. against peers pursuing similar technology classes.

Cyber Physical Sy…

5
Cygnus Bioscience…

5
Cymbet

5
Cymer-dayton

5
Cyndrx

5
Cystech

5
Cyto365 AB

5
Cytoaurora Biotec…

5
Cymmetrik Enterpr… ◀

5

What this shows Cymmetrik holds 5 patents at rank #45,706, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cymmetrik

By rank, the assignees closest to #45,706 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cymmetrik's primary technology class.

Cymmetrik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

31 Top 63% higher than 37% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Cymmetrik Enterprise Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2021	1	20.0%
2022	1	20.0%
2024	1	20.0%
2025	1	20.0%

Which technologies does Cymmetrik Enterprise Co., Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1

G06K - GRAPHICAL DATA READING ; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 1

H01Q - ANTENNAS, i.e. RADIO AERIALS 1

H04B - TRANSMISSION 1

G01K - MEASURING TEMPERATURE; MEASURING QUANTITY OF HEAT; THERMALLY-SENSITIVE ELEMENTS NOT OTHERWISE PROVIDED FOR 1

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 1

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 1

H05K - PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Simple

Where it ranks

Overall rank by patents

#45,706

Across all tracked assignees

Innovation Score

31.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cymmetrik Enterprise Co., Ltd. hold?

Cymmetrik Enterprise Co., Ltd. holds 5 US granted patents filed between 2020 and 2025, spanning 10 technology areas.

What is Cymmetrik Enterprise Co., Ltd.'s Innovation Score?

Cymmetrik Enterprise Co., Ltd. has an Innovation Score of 31.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cymmetrik Enterprise Co., Ltd. focus on?

Cymmetrik Enterprise Co., Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 1 patents. The company has filed patents in 10 CPC subclasses total.

Is Cymmetrik Enterprise Co., Ltd.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cymmetrik Enterprise Co., Ltd..

What does claim depth mean for Cymmetrik Enterprise Co., Ltd.'s patents?

Cymmetrik Enterprise Co., Ltd.'s patents average 11.8 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Cymmetrik Enterprise Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cymmetrik's 5 grants land it in the top 63% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cymmetrik ranks #45,706 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.